TrialSite recently showcased the consolidating contract research organization (CRO) market, with a number of giant organizations now emerging to battle it out on the global…
Rapid growth in any business certainly attracts positive attention and in the world of clinical research trial sites even more so as scale becomes ever…
While life sciences-focused mergers and acquisition activity in 2020 was expected to dip, at least a bit due to the pandemic—as compared to 2019 pace—this…
Artificial intelligence (AI) will become an ever more important underlying force in the drug development process, from discovery through clinical research operations to regulatory submissions…
As the clinical research space continues to adapt, advance and evolve, TrialSite chronicles a number of trends, including the ongoing entry of private equity into…
A Rockville Maryland-based global, full-service clinical research organization (CRO) recently acquired a European-based CRO called Neox s.r.o., with over 150 employees involved in outsourcing clinical…
Private equity-backed site organization roll-up Velocity Clinical Research purchased eStudySite, contributing two trial site locations in San Diego, California to its North American site portfolio,…
Germany-based Bayer acquired AskBio’s industry leading AAV-based gene therapy platform to accelerate its ability to bring urgently needed treatments to patients across multiple disease areas…
Paul Evans and Velocity are on the move again buying another research site in their quest to build a seamlessly integrated national clinical research site…
Merck (NYSE:MRK), known as MSD outside the United States and Canada, has moved into the race to develop COVID-19 treatments, including vaccines and a possible…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
